Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatty acid regulation and phosphatidylethanolamine biosynthesis are important for hepatitis E virus replication.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Dairy cows infected with influenza A(H5N1) reveals low infectious dose and transmission barriers.

Nature communications·2026
Same author

Vaccination with an African Swine Fever Virus Multiepitope Protein Chitosan Nanoparticle-Based Subunit Vaccine Elicits Robust Immune Responses In Vivo.

Vaccines·2026
Same author

Spillover of Rat Hepatitis E Virus into Humans: An Emerging Zoonosis?

Future virology·2025
Same author

Age-based host response to Turkey arthritis reovirus in commercial Turkeys in the presence of maternally derived antibodies.

BMC veterinary research·2025
Same author

The zoonotic LCK-3110 strain of Rocahepevirus ratti leads to mild infection in chickens after experimental inoculation.

Virus research·2024
Same journal

Enrichment of the high-risk ST131 clone among ciprofloxacin-resistant Escherichia coli in a single-center cohort from Turkey: a molecular surveillance study.

BMC infectious diseases·2026
Same journal

Association between clinical symptoms and time to pharyngeal PCR negativity among mild omicron COVID-19 patients: a retrospective study.

BMC infectious diseases·2026
Same journal

Prevalence and socio-demographic factors associated with transfusion transmissible infections among voluntary blood donors in Kigali, Rwanda.

BMC infectious diseases·2026
Same journal

Letter to the editor regarding clinical characteristics and factors associated with in-hospital post-surgical mortality in COVID-19 patients at a tertiary care center in Karachi, Pakistan.

BMC infectious diseases·2026
Same journal

A case of Kocuria varians-induced cervical spondylodiscitis with suspected acupuncture-related infection: review and discussion.

BMC infectious diseases·2026
Same journal

Preventive effectiveness of respiratory syncytial virus vaccination in older adults: a multi-institutional cohort study.

BMC infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2025

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

8.6K

Hepatitis E virus immunosuppressed animal models.

Kush Kumar Yadav1,2, Scott P Kenney3,4

  • 1Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Ave, Wooster, OH, 44691, USA.

BMC Infectious Diseases
|September 12, 2024
PubMed
Summary
This summary is machine-generated.

Hepatitis E virus (HEV) causes serious illness in immunocompromised individuals, particularly organ transplant recipients. This review focuses on immunosuppressed animal models to study chronic HEV infection and its liver pathology.

Keywords:
AnimalChronicHepatitisHumansImmunosuppressedInfectionModels

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.2K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Related Experiment Videos

Last Updated: Jun 13, 2025

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

8.6K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.2K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.7K

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Hepatitis E virus (HEV) is an emerging pathogen causing significant illness in immunocompromised populations, including solid organ transplant (SOT) recipients, cancer patients, and those with HIV.
  • Chronic HEV infections are common in these groups, exacerbated by factors like blood transfusions, leading to viral persistence and adaptation.
  • Understanding HEV pathogenesis in immunosuppressed individuals is crucial due to increasing SOT procedures and associated risks.

Purpose of the Study:

  • To review recent advancements in immunosuppressed animal models for studying chronic Hepatitis E virus (HEV) infection.
  • To emphasize the pathogenesis, immune correlates, and liver pathology of chronic HEV in these models.
  • To highlight the need for suitable models to understand HEV disease patterns in high-risk patient groups.

Main Methods:

  • Review of current literature on HEV pathogenesis in immunosuppressed animal models.
  • Analysis of naturally occurring HEV strains in various animal species with zoonotic potential.
  • Focus on studies detailing immune responses and liver pathology in chronic HEV infection.

Main Results:

  • Immunosuppression facilitates HEV persistence and chronic infection, allowing viral adaptation and potentially worse disease outcomes.
  • Various animal models exist, some naturally infected with HEV strains transmissible to humans, serving as valuable research tools.
  • Chronic HEV infection in immunosuppressed hosts leads to distinct liver pathology and altered immune correlates.

Conclusions:

  • Immunosuppressed animal models are essential for investigating the complex pathogenesis of chronic HEV infection.
  • These models aid in understanding viral adaptation, immune responses, and liver damage in vulnerable patient populations.
  • Further research using these models can inform strategies for managing HEV in immunocompromised individuals, especially SOT recipients.